Hélène Dubois-Pot-Schneider received her PhD in Molecular and Cellular Biology at the University of Strasbourg in 2009. While working on her thesis at UMR CNRS 7104 – INSERM (IGBMC), she studied the transcription factor Net/Elk-3, a regulator of HIF1-alpha.SheI also performed her postdoctoral work in the INSERM 991 unit: Liver, Metabolism and Cancer at Rennes. There, she identified molecular mechanisms involved during liver cancer progression and resistance to conventional chemotherapy. In 2014, she held a position as associate professor at the University of Lorraine (Metz). At UMR CNRS 7565 (SRSMC), she studied the potential of new natural and synthetic (antitumor and antimicrobial) drugs and evaluate their hepatotoxicity. Since 2018, she has been working at UMR 7039 CNRS (CRAN). Her research interests include the molecular characterisation of mechanisms involved during cancer progression and treatment resistance.